Cardiff Oncology, Inc. (CRDF)
0.998
+0.12
(+13.40%)
USD |
NASDAQ |
Aug 24, 16:00
0.9968
0.00 (0.00%)
After-Hours: 20:00
Cardiff Oncology Shareholders Equity (Quarterly) : 26.53M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.53M |
| March 31, 2026 | 34.71M |
| December 31, 2025 | 45.39M |
| September 30, 2025 | 48.79M |
| June 30, 2025 | 58.61M |
| March 31, 2025 | 70.88M |
| December 31, 2024 | 82.95M |
| September 30, 2024 | 49.39M |
| June 30, 2024 | 52.39M |
| March 31, 2024 | 60.89M |
| December 31, 2023 | 69.74M |
| September 30, 2023 | 77.83M |
| June 30, 2023 | 86.58M |
| March 31, 2023 | 96.50M |
| December 31, 2022 | 106.34M |
| September 30, 2022 | 113.21M |
| June 30, 2022 | 120.47M |
| March 31, 2022 | 130.10M |
| December 31, 2021 | 140.56M |
| September 30, 2021 | 133.54M |
| June 30, 2021 | 138.92M |
| March 31, 2021 | 124.82M |
| December 31, 2020 | 130.33M |
| September 30, 2020 | 33.52M |
| June 30, 2020 | 24.38M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.143M |
| December 31, 2019 | 8.283M |
| September 30, 2019 | 6.656M |
| June 30, 2019 | 8.848M |
| March 31, 2019 | 9.686M |
| December 31, 2018 | 10.08M |
| September 30, 2018 | 13.98M |
| June 30, 2018 | 17.48M |
| March 31, 2018 | 4.679M |
| December 31, 2017 | 6.506M |
| September 30, 2017 | 3.945M |
| June 30, 2017 | 3.511M |
| March 31, 2017 | 10.68M |
| December 31, 2016 | 19.77M |
| September 30, 2016 | 26.77M |
| June 30, 2016 | 32.57M |
| March 31, 2016 | 41.16M |
| December 31, 2015 | 48.70M |
| September 30, 2015 | 54.86M |
| June 30, 2015 | 18.12M |
| March 31, 2015 | 23.56M |
| December 31, 2014 | 8.350M |
| September 30, 2014 | 12.35M |
| June 30, 2014 | 17.33M |
| March 31, 2014 | 17.75M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ocugen, Inc. | -16.56M |
| CytomX Therapeutics, Inc. | 302.07M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.33M |
| Total Liabilities (Quarterly) | 10.80M |
| Debt to Equity Ratio | 0.0172 |
| Current Ratio | 3.296 |
| Net Debt Paydown Yield | 0.20% |